Gasparro F P, Battista J, Song J, Edelson R L
Department of Dermatology, Yale University, New Haven, Connecticut 06510.
J Invest Dermatol. 1988 Feb;90(2):234-6. doi: 10.1111/1523-1747.ep12462304.
A new method has been developed to extract 8-methoxypsoralen (8-MOP) from human plasma and to prepare samples for high performance liquid chromatography (HPLC) analysis. Plasma samples are passed through solid phase extraction cartridges that are essentially HPLC "microcolumns" consisting of a bonded silica sorbent that, after activation, selectively retain 8-MOP and then release it when exposed to an eluting solvent. The 8-MOP collected from the cartridge is analyzed by reversed phase HPLC. With this new technique, the 8-MOP is completely recovered and as little as 10 ng/ml can be detected in a 1-ml plasma sample. The average plasma level in a series of 17 patients who had ingested Oxsoralen (approximately 0.6 mg/kg) was 117 ng/ml (+/- 79).
已开发出一种从人血浆中提取8-甲氧基补骨脂素(8-MOP)并制备用于高效液相色谱(HPLC)分析样品的新方法。血浆样品通过固相萃取柱,这些柱本质上是HPLC“微柱”,由键合硅胶吸附剂组成,活化后可选择性保留8-MOP,然后在暴露于洗脱溶剂时将其释放。从柱中收集的8-MOP通过反相HPLC进行分析。采用这种新技术,8-MOP可完全回收,在1 ml血浆样品中可检测到低至10 ng/ml的含量。17名摄入甲氧沙林(约0.6 mg/kg)的患者的系列平均血浆水平为117 ng/ml(±79)。